Mackenzie Financial Corp Zai Lab LTD Transaction History

Mackenzie Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $485,370 - $930,161	-8,841 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$105.0 - $178.37 $2.68 Million - $4.54 Million	-25,477 Reduced 74.24%	8,841 $932,000
Q2 2021 Aug 11, 2021	SELL	$125.11 - $180.0 $3.54 Million - $5.09 Million	-28,290 Reduced 45.19%	34,318 $6.07 Million
Q1 2021 May 14, 2021	BUY	$126.27 - $191.71 $2.59 Million - $3.93 Million	20,507 Added 48.71%	62,608 $8.35 Million
Q4 2020 Feb 10, 2021	BUY	$81.94 - $135.34 $3.45 Million - $5.7 Million	42,101 New	42,101 $5.7 Million

123

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.